NCT01643252View on ClinicalTrials.gov

Safety and Efficacy Study for Corneal Collagen Cross-Linking in Eyes With Corneal Ectasia After Refractive Surgery

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 31, 2012

Conditions
Corneal Ectasia
Interventions
DRUG

riboflavin: 0.12% riboflavin ophthalmic solution with the KXL system

Subjects will receive 0.12% riboflavin ophthalmic solution (VibeX) followed by irradiation with the KXL system at 30mW/cm\^2 for 4 minutes

DRUG

placebo: 0.0% riboflavin ophthalmic solution with the KXL system

Subjects will receive 0.0% riboflavin ophthalmic solution (placebo) followed by irradiation with the KXL system at 30mW/cm\^2 for 4 minutes

Sponsors
All Listed Sponsors
lead

Glaukos Corporation

INDUSTRY